Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

July 28, 2025 Investing 1 Min Read

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Investing
Chemical assay confirms high-grade uranium
September 17, 2025

Investing
How to Invest in Manganese Stocks
September 17, 2025

Investing
Reinstatement to Quotation
September 17, 2025

Investing
$14M Placement to Fund Acquisition & Exploration
September 17, 2025
Categories
- Business (210)
- Investing (564)
- Politics (664)
- Stock (176)